Jim P Abraham

6PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro

|Feb 11, 2025
Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

Daniel Magee, Valeriy Domenyuk, Jim Abraham

|Feb 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.

Moh'd M Khushman, Michael D Toboni, Joanne Xiu

|Aug 03, 2022
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.

Sungyong You, Minhyung Kim, Xen Ping Hoi

|Sep 01, 2021
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.

Roberto Moretto, Andrew Elliott, Jian Zhang

Pageof 1